Marker Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRKR for the last quarter is 1.24 M USD, and it's 17.75% higher compared to the previous quarter. The net income of Q1 24 is -2.39 M USD.